Lifestyles, Arterial Aging & Intestinal Microbiota (MIVAS III Study)

Status Completed

Clinical Trial Summary

This is an observational cross-sectional study whose objective is to analyse associations between the intestinal and salivate microbiota with lifestyles (eating patterns, physical activity, tobacco and alcohol consumption), arterial aging and cognitive function. It will take place in five different research units located in Spain

Clinical Trial Description

Aim: To analyze the association of lifestyles (eating patterns, physical activity, tobacco and alcohol consumption) with the intestinal and salivate microbiota and its relationship with arterial aging and cognitive function in subjects without cardiovascular disease in Spain and Portugal. In addition, the mediating role of the intestinal microbiota in the relationship of lifestyles with arterial aging and cognitive function will be analyzed. Design: A cross-sectional study with a case-control analysis, to analyze the association of microbiota patterns with arterial ageing. Setting: the study will develop the research network in health prevention and promotion (Rediapp) and in the Iberian network on arterial structure and the Cancer Research Center of Salamanca. Study population: 1000 subjects aged 45 to 74 years without cardiovascular disease, will be selected. Variables: Demographic, anthropometric and habits (tobacco and alcohol). A dietary pattern through a frequency consumption questionnaire (FFQ), the software of the EVIDENT III and the Mediterranean Diet adherence questionnaire. Physical activity: International Physical Activity Questionnaire (IPAQ), Marshall Questionnaire and Accelerometer, Actigraph. Body composition (Inbody 230 impedance meter). Arterial aging: Medium intimate carotid thickness (Sonosite Micromax); Analysis (PWA) and pulse wave velocity (cf-PWV), (Sphygmocor System). Cardio Ankle Vascular Index (CAVI), ba-PWV and ankle-brachial index (Vasera VS-2000®). With Ambulatory Pulse Wave Analysis (Microsoft®), the PAIx and CAIx and the heart rate variability will be measured. The vascular damage in the retina, heart, kidney, brain and cardiovascular risk will be measured. Intestinal microbiota with the OMNIgene GUT kit (OMR -200) and analysis of the 16S rRNA microbiome profile by massive sequentiation. (Lifestyles, arterial aging, neurocognition, microbiota) ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04924907
Study type	Observational
Source	Fundacion para la Investigacion y Formacion en Ciencias de la Salud
Contact
Status	Completed
Phase
Start date	April 21, 2021
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06133634` - Fisetin to Improve Vascular Function in Older Adults	Phase 1/Phase 2
Completed	`NCT05872139` - Role of Mitochondrial-derived Oxidative Stress to Promote Vascular Endothelial Dysfunction in Non-exercisers With Aging	N/A
Recruiting	`NCT04558450` - Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)	N/A
Recruiting	`NCT05095688` - Relationship Between Adipose Tissue Distribution and Arterial Stiffness in HFpEF
Not yet recruiting	`NCT05943457` - Vitamin K2 Supplementation in Adult Episodic Migraine	N/A
Not yet recruiting	`NCT04900610` - The Effect of Vitamin K2 Supplementation on Arterial Stifness and Cardiovascular Events in PEritonial DIAlysis	N/A
Completed	`NCT02226055` - An Investigation Into the Cardiovascular Risk and Aetiology of CKDu in Sri Lanka	N/A
Completed	`NCT01559896` - Egg Protein Hydrolysate and Vascular Function	N/A
Completed	`NCT04049162` - Blueberry Enhances Activity and Cognition Through Increased Vascular Efficiency	N/A
Completed	`NCT05537246` - The Relationship Between Arterial Stiffness and Hemodynamic Responses in Patients With Spinal Anesthesia
Completed	`NCT06151054` - Relationship Between Aortic Parietal Inflammation on 18F-FDG PET Scan and Arterial Stiffness as a Function of Age
Completed	`NCT02218268` - Arterial Stiffness in Type I Diabetes Mellitus	N/A
Completed	`NCT00547040` - Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients
Completed	`NCT02821780` - CADASIL Disease Discovery
Completed	`NCT05719090` - Acute Effects of Autoregulated and Non-autoregulated Blood Flow Restrictive Exercise on Indices of Arterial Stiffness	N/A
Completed	`NCT04549324` - Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy
Completed	`NCT05022498` - Individual Variability of Coronary Heart Disease Risk Markers and Sleep Responses to Exercise	N/A
Completed	`NCT03415880` - Light Intensity Physical Activity Trial	N/A
Completed	`NCT03560804` - Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two Drugs	N/A
Recruiting	`NCT05781737` - Inflammatory Bowel Disease and Atherosclerosis Development

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Lifestyles, Arterial Aging and Intestinal Microbiota (MIVAS III Study)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms